ESR1 and breast carcinoma: Specifically, studies have demonstrated that estrogen receptor (ER) and progesterone receptor (PR) positive breast cancer exhibit a negative association with HDL-C and LDL-C levels, with HDL-C levels being independently linked to ER and PR positive breast cancer in postmenopausal women (26).